Bracebridge Capital LLC’s Biote Corp. Warrant BTMDW Stock Holding History

Bracebridge Capital LLC’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-77,549	Closed	-$32.6K	–	83
2023 Q1	$32.6K	Hold	77,549	–	–	0.01%	49
2022 Q4	$23.3K	Hold	77,549	–	–	﹤0.01%	76
2022 Q3	$27K	Hold	77,549	–	–	﹤0.01%	96
2022 Q2	$33K	Hold	77,549	–	–	0.01%	97
2022 Q1	$43K	Buy	+77,549	New	+$36.8K	﹤0.01%	98

Other funds holding BTMDW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bracebridge Capital LLC's BTMDW Position: Q2 2023 in Review

Bracebridge Capital LLC sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 77,549 shares — an estimated $32.6K sold.

Bracebridge Capital LLC first reported a position in BTMDW in Q1 2022 and held it in 5 quarters. The position peaked at $43K in Q1 2022. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

Bracebridge Capital LLC reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Bracebridge Capital LLC sold 77,549 Biote Corp. Warrant shares in Q2 2023, an estimated $32.6K.
Bracebridge Capital LLC first reported a position in Biote Corp. Warrant in Q1 2022 and held it in 5 quarters.
Bracebridge Capital LLC's Biote Corp. Warrant position peaked at $43K in Q1 2022.
2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on Bracebridge Capital LLC's 13F filing for Q2 2023, filed 14 Aug 2023.